We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
Cap. Flow
-$248M
Cap. Flow %
-0.63%
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Financials 10.78%
3 Industrials 9.91%
4 Healthcare 9.19%
5 Consumer Staples 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
3251
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6K ﹤0.01%
44
-8
-15% -$772
ITCL
3252
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$6K ﹤0.01%
669
-13
-2% -$116
TCRR
3253
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$6K ﹤0.01%
400
VMM
3254
DELISTED
Delaware Investments Minnesota Municipal Income Fund II
VMM
$6K ﹤0.01%
459
-6,951
-94% -$90.9K
BMTC
3255
DELISTED
Bryn Mawr Bank Corp
BMTC
$6K ﹤0.01%
152
CLDR
3256
DELISTED
Cloudera, Inc.
CLDR
$6K ﹤0.01%
500
CORE
3257
DELISTED
Core Mark Holding Co., Inc.
CORE
$6K ﹤0.01%
208
+58
+39% +$1.61K
HOME
3258
DELISTED
At Home Group Inc.
HOME
$6K ﹤0.01%
1,000
-297
-23% -$2.42K
BLPH
3259
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$6K ﹤0.01%
1,221
COWN
3260
DELISTED
Cowen Inc. Class A Common Stock
COWN
$6K ﹤0.01%
393
-441
-53% -$6.62K
HIBB
3261
DELISTED
Hibbett, Inc. Common Stock
HIBB
$6K ﹤0.01%
+199
New +$5.05K
ARCB icon
3262
ArcBest
ARCB
$3.44B
$5K ﹤0.01%
184
ATRA icon
3263
Atara Biotherapeutics
ATRA
$71.2M
$5K ﹤0.01%
13
-1
-7% -$345
BMRC icon
3264
Bank of Marin Bancorp
BMRC
$466M
$5K ﹤0.01%
120
CLDT
3265
Chatham Lodging
CLDT
$630M
$5K ﹤0.01%
248
DAKT icon
3266
Daktronics
DAKT
$941M
$5K ﹤0.01%
800
EGHT icon
3267
8x8 Inc
EGHT
$247M
$5K ﹤0.01%
258
EQBK icon
3268
Equity Bancshares
EQBK
$1.03B
$5K ﹤0.01%
163
FIZZ icon
3269
National Beverage
FIZZ
$2.87B
$5K ﹤0.01%
190
+150
+375% +$3.6K
FLWS icon
3270
1-800-Flowers.com
FLWS
$245M
$5K ﹤0.01%
317
GTES icon
3271
Gates Industrial Corporation Ltd.
GTES
$6.81B
$5K ﹤0.01%
380
HCI icon
3272
HCI Group
HCI
$2.28B
$5K ﹤0.01%
112
HRTX icon
3273
Heron Therapeutics
HRTX
$86.3M
$5K ﹤0.01%
200
HSII
3274
DELISTED
Heidrick & Struggles
HSII
$5K ﹤0.01%
148
IEF icon
3275
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$5K ﹤0.01%
+1,446
New +$161K

Similar funds

US Bancorp's Q4 2019 Portfolio in Review

As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
  • US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
  • US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
  • US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
  • US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
  • US Bancorp opened 218 new positions and closed 148 in Q4 2019.
  • US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.